Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Dina R. Mody, M.D.

Dina R. Mody, M.D.


Dina R. Mody, M.D.

Dina R. Mody, M.D.

Senior Member
The Methodist Hospital Research Institute
Medical Director, Cytopathology
Director, Cytopathology Fellowship
Associate Director, Pathology Residency Program
Department of Pathology and Genomicf Medicine
The Methodist Hospital Physician Organization
Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College of Cornell University

E-mail: dmody@houstonmethodist.org
Phone: 713-441-6483
Fax: 713-793-1603


M.D.   Bombay University, Bombay, India

Postdoctoral Training

Rotating Internship, KEM Hospital, Bombay, India
Pathology Residency, Baylor College of Medicine, Houston, TX



After completing her postdoctoral training, Dr. Mody joined the faculty at the Baylor College of Medicine in Houston, Texas as an Instructor of Pathology in 1984. She received her full professorship there in 2000, and held the Ibrahim Ramzy Endowed Chair. Dr. Mody is currently President elect of the American Society of Cytopathology (ASC). She has given numerous workshops, teleconferences, symposia and lectures at its national meetings. She has served on the Executive Board, the Scientific Program Committee and chaired the Quality Assurance Committee. She co-chaired the Practice Guidelines Committee, which developed the Cervical Cytology Practice Guidelines for which she received the President’s Award of the ASC in 1999. In 2002, she received the Lansky Award of the College of American Pathologists (CAP) for her leadership role in cytology, and has served as Chair of the CAP Cytopathology Resource Committee. In 2004, Dr. Mody was appointed to the Clinical Laboratory Improvement Advisory Committee (CLIAC) of the CDC, where she serves as an advisor on cytology issues to the CDC and CMS. Previous leadership positions include President of the Texas Society of Cytology, and Chair of Scientific Program of the Houston Society of Clinical Pathologists.

Description of Research

Dr. Mody’s previous research interests have been in the area of glandular lesions in cervicovaginal cytology and pathology, as well as bone and soft tissue cytology and pathology. Her early papers on tissue and bone reactions to implants were instrumental to the defense when reactions to breast implants were the subject of major litigation in the United States. Dr. Mody’s current research focuses on the application of HPV testing and genotyping in low and high risk populations, application of new imaging modalities to diagnostic cytopathology, and immunohistochemical and molecular testing in body fluid cytology.

Major Areas of Research

Bone cytology, soft tissue cytology, pathology, HPV, genotyping

Recent Publications

Koen TM, Mody DR, Scheiber-Pacht M, Fairley T, Thrall MJ. Limiting the use of atypical/inconclusive as a category in nongynecologic cytology specimens. Arch Pathol Lab Med. 2010 Jul;134(7):1016-9.

Halloush RA, Lavrovskaya E, Mody DR, Lager D, Truong L. Diagnosis and typing of systemic amyloidosis: The role of abdominal fat pad fine needle aspiration biopsy. Cytojournal. 2010 Jan 15;6:24.

Thrall MJ, Smith DA, Mody DR. Women >or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women? Diagn Cytopathol. 2010 Jun;38(6):407-12.

Kosarac O, Carrum G, Mody D, Takei H. Cytologic findings in allogeneic and autologous bone marrow transplant patients with pulmonary symptoms: a 9-year follow-up study. Acta Cytol. 2009 Sep-Oct;53(5):565-70.

Ge Y, Smith D, Schwartz MR, Mody DR. Image-guided ThinPrep Papanicolaou tests and cotesting with high-risk human papillomavirus in women aged 30 years and older in a low-risk private practice population. Cancer Cytopathol. 2009 Oct 25;117(5):326-32.

Raparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med. 2009 May;133(5):787-90.

Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. Cancer. 2008 Dec 25;114(6):474-80.

Steinman S, Smith D, Chandler N, Dhurandhar B, Di Filippo L, Scheiber-Pact M, Mody DR. Morphologic, patient and interpreter profiles of high-risk human papillomavirus-positive vs.-negative cases of atypical squamous cells of undetermined significance. Acta Cytol. 2008 May-Jun;52(3):279-85.

Lyons-Boudreaux V, Mody DR, Zhai J, Coffey D. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med. 2008 Jan;132(1):23-8.

Renshaw AA, Mody DR, Walsh M, Bentz JS, Colgan TJ; Cytopathology Resource Committee, College of American Pathologists. The significance of certification in liquid-based cytology and performance in the college of american pathologists interlaboratory comparison program in cervicovaginal cytopathology. Arch Pathol Lab Med. 2006 Sep;130(9):1269-72.